SMDAM
HZNP

Sumitomo Mitsui DS Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-18,149
Closed -$2.1M – 813
2023
Q3 		$2.1M Sell
18,149
-98
-0.5% -$10.5K 0.03% 384
2023
Q2 		$1.88M Buy
18,247
+2,133
+13% +$225K 0.03% 417
2023
Q1 		$1.76M Hold
16,114
– – 0.03% 410
2022
Q4 		$1.83M Hold
16,114
– – 0.04% 378
2022
Q3 		$997K Buy
16,114
+2,332
+17% +$163K 0.02% 498
2022
Q2 		$1.1M Buy
13,782
+385
+3% +$36.5K 0.03% 465
2022
Q1 		$1.41M Sell
13,397
-55
-0.4% -$5.36K 0.03% 422
2021
Q4 		$1.45M Buy
13,452
+173
+1% +$18.9K 0.03% 440
2021
Q3 		$1.45M Sell
13,279
-90
-0.7% -$9.34K 0.03% 405
2021
Q2 		$1.25M Buy
13,369
+920
+7% +$84.7K 0.03% 441
2021
Q1 		$1.15M Buy
12,449
+113
+0.9% +$9.54K 0.03% 445
2020
Q4 		$902K Buy
+12,336
New +$917K 0.03% 487

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's HZNP Position: Q4 2023 in Review

Sumitomo Mitsui DS Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 18,149 shares — an estimated $2.1M sold.

Sumitomo Mitsui DS Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $2.1M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Sumitomo Mitsui DS Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 18,149 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.1M.
  • Sumitomo Mitsui DS Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Sumitomo Mitsui DS Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.1M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.